Question 1

How does ValGenesis demonstrate measurable impact on validation efficiency and audit readiness in life sciences organisations?

Accepted Answer

ValGenesis is designed to replace paper and spreadsheet-based validation with standardised digital workflows and a single system of record, which can reduce rework and cycle times while improving traceability. Organisations commonly report more consistent documentation, faster retrieval of evidence during inspections, and better oversight across sites, although the exact magnitude of improvement varies by implementation and is typically documented in internal or vendor case studies rather than peer‑reviewed trials

Question 2

What are the key regulatory and compliance considerations when using ValGenesis for GxP validation activities?

Accepted Answer

ValGenesis is intended to support GxP-compliant validation by enforcing structured workflows, electronic records, and audit trails aligned with regulations such as 21 CFR Part 11 and comparable data integrity expectations. However, it is not a substitute for an organisation’s own computerised systems validation and quality management; each deployment must be validated in its specific environment, with documented procedures, risk assessments, and oversight to satisfy regulators and internal QA.

Question 3

What should digital transformation and QA leaders expect in terms of integration effort, scalability, and total cost of ownership?

Accepted Answer

Implementing ValGenesis typically involves integrating with existing quality, manufacturing, and IT systems, configuring templates and workflows, and training validation and QA teams, so dedicated project and change‑management resources are usually required. Once established, the platform is designed to scale across multiple sites and product lines, with total cost of ownership driven more by scope, configuration complexity, and support needs than by software licensing alone.

Useful Links

Our Services

Contact Us